Safety Considerations: Tirzepatide is not recommended for those with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, a history of pancreatitis, or severe gastrointestinal disease
Discover this new bundle containing 30 servings of Immunocal Platinum and 30 servings of our Booster, filled with minerals and vitamins from +50 fruits and veggies.
With the 2026 landscape of weight management becoming increasingly competitive, diversifying your delivery methods is a savvy move, but it requires a nuanced clinical approach to manage both patient health and business risk
Singh YJ, Grewal SK, Gill RK
Clinical trial results (STEP trials): Average weight loss: 15-17% of body weight At 68 weeks on 2.4mg dose: 33 pounds for a 200-pound person 86% of participants lost at least 5% body weight 50% lost at least 15% body weight This is pharmaceutical-grade weight loss
They cannot be let go of and just sit freely in the skin like most of those videos that are linked show